The mortality rate for prostate malignant neoplasms in Brazil is expected to rise gradually from 16.65 thousand male deaths in 2024 to 17.37 thousand in 2028. The year-on-year increase appears consistent, with a growth of approximately 1.08% each year. Such trends indicate a steady upward trajectory over the five-year forecast period.
Looking ahead, key trends to watch include advancements in medical treatments, increased awareness and screening initiatives, and potential public health interventions. These factors may influence the projected increase in mortality rates, possibly mitigating the upward trend in prostate cancer-related deaths.
